Document Classification

Section Type: RESULTS

Text: Treatment with pioglitazone as compared with placebo was associated with significantly reduced levels of fasting glucose (a decrease of 11. 7 mg per deciliter vs. 8. 1 mg per deciliter [0. 7 mmol per liter vs. 0. 5 mmol per liter], P < 0. 001), 2-hour glucose (a decrease of 30. 5 mg per deciliter vs. 15. 6 mg per deciliter [1. 6 mmol per liter vs. 0. 9 mmol per liter], P < 0. 001), and HbA (1c) (a decrease of 0. 04 percentage points vs. an increase of 0. 20 percentage points, P < 0. 001).